Literature DB >> 11956128

Myocardial fibrosis in chronic aortic regurgitation: molecular and cellular responses to volume overload.

Jeffrey S Borer1, Sharada Truter, Edmund M Herrold, Domenick J Falcone, Magda Pena, John N Carter, Themy F Dumlao, Jennifer A Lee, Phyllis G Supino.   

Abstract

BACKGROUND: Myocardial fibrosis is common in patients with chronic aortic regurgitation (AR). Experimentally, fibrosis with disproportionate noncollagen extracellular matrix (ECM) elements precedes and contributes to heart failure in AR. METHODS AND
RESULTS: We assessed [3H]-glucosamine and [3H]-proline incorporation in ECM, variations in cardiac fibroblast (CF) gene expression, and synthesis of specific ECM proteins in CF cultured from rabbits with surgically induced chronic AR versus controls. To determine whether these variations are primary responses to AR, normal CF were exposed to mechanical strain that mimicked that of AR. Compared with normal CF, AR CF incorporated more glucosamine (1.8:1, P=0.001) into ECM, showed fibronectin gene upregulation (2.0:1, P=0.02), and synthesized more fibronectin (2:1 by Western blot, P<0.06; 1.5:1 by affinity chromatography, P=0.02). Proline incorporation was unchanged by AR (1.1:1, NS); collagen synthesis was unaffected (type I, 0.9:1; type III, 1.0:1, NS). Normal CF exposed to cyclical mechanical strain during culture showed parallel results: glucosamine incorporation increased with strain (2.1:1, P<0.001), proline incorporation was unaffected (1.1:1, NS), fibronectin gene expression (1.6:1, P=0.07) and fibronectin synthesis (Western analysis, 1.3:1, P<0.01; chromatography, 1.9:1, NS) were upregulated.
CONCLUSIONS: In AR, CF produce abnormal proportions of noncollagen ECM, specifically fibronectin, with relatively little change in collagen synthesis. At least in part, this is a primary response to strain imposed on CF by AR. Further study must relate these findings to the pathogenesis of heart failure in AR.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11956128     DOI: 10.1161/01.cir.0000014419.71706.85

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  36 in total

Review 1.  The extracellular matrix in myocardial injury, repair, and remodeling.

Authors:  Nikolaos G Frangogiannis
Journal:  J Clin Invest       Date:  2017-05-01       Impact factor: 14.808

Review 2.  Aortic valvular imaging with cardiovascular magnetic resonance: seeking for comprehensiveness.

Authors:  Gianluca De Rubeis; Nicola Galea; Isabella Ceravolo; Gian Marco Dacquino; Iacopo Carbone; Carlo Catalano; Marco Francone
Journal:  Br J Radiol       Date:  2019-07-18       Impact factor: 3.039

Review 3.  Therapeutic angiogenesis with exosomal microRNAs: an effectual approach for the treatment of myocardial ischemia.

Authors:  Toktam Moghiman; Bita Barghchi; Seyed-Alireza Esmaeili; Mahmoud Mohammadzadeh Shabestari; Seyedeh Samaneh Tabaee; Amir Abbas Momtazi-Borojeni
Journal:  Heart Fail Rev       Date:  2021-01       Impact factor: 4.214

4.  Differential patterns of replacement and reactive fibrosis in pressure and volume overload are related to the propensity for ischaemia and involve resistin.

Authors:  Elie R Chemaly; Soojeong Kang; Shihong Zhang; LaTronya McCollum; Jiqiu Chen; Ludovic Bénard; K-Raman Purushothaman; Roger J Hajjar; Djamel Lebeche
Journal:  J Physiol       Date:  2013-09-09       Impact factor: 5.182

Review 5.  Cardiac T(1) imaging.

Authors:  Michael Jerosch-Herold; Raymond Y Kwong
Journal:  Top Magn Reson Imaging       Date:  2014-02

6.  Survival after Aortic Valve Replacement for Aortic Regurgitation: Prediction from Preoperative Contractility Measurement.

Authors:  Jeffrey S Borer; Phyllis G Supino; Edmund McM Herrold; Antony Innasimuthu; Clare Hochreiter; Karl Krieger; Leonard N Girardi; O Wayne Isom
Journal:  Cardiology       Date:  2018-08-23       Impact factor: 1.869

Review 7.  Assessment and management of aortic valve disease in patients with left ventricular dysfunction.

Authors:  Mackram F Eleid; Sunil Mankad; Paul Sorajja
Journal:  Heart Fail Rev       Date:  2013-01       Impact factor: 4.214

Review 8.  Managing the right ventricular outflow tract for pulmonary regurgitation after tetralogy of Fallot repair.

Authors:  Michael Hauser; Andreas Eicken; Andreas Kuehn; John Hess; Sohrab Fratz; Peter Ewert; Harald Kaemmerer
Journal:  Heart Asia       Date:  2013-06-25

Review 9.  Drug Therapy for Heart Valve Diseases.

Authors:  Jeffrey S Borer; Abhishek Sharma
Journal:  Circulation       Date:  2015-09-15       Impact factor: 29.690

10.  Hypertrophy signaling pathways in experimental chronic aortic regurgitation.

Authors:  Niels Thue Olsen; Veronica L Dimaano; Thomas Fritz-Hansen; Peter Sogaard; Khalid Chakir; Kristian Eskesen; Charles Steenbergen; David A Kass; Theodore P Abraham
Journal:  J Cardiovasc Transl Res       Date:  2013-07-26       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.